Evidence map›Paper›PMID 16081970›Full record

ArticleJournal of clinical microbiology2005

Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Laure Diancourt, Virginie Passet, Jan Verhoef, Patrick A D Grimont, Sylvain Brisse

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 741 papers.

0numbers the graph read from it
0cells of the map it votes in
741citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

741 citing papers in PubMed.

  1. Article
  2. In vitro and in vivo antibacterial activity of oral tebipenem in combination with novel β-lactamase inhibitors (avibactam, relebactam, vaborbactam) against KPC-producing Enterobacterales.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Molecular Characterization and Clinical Outcomes ofChildren (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Dynamics of clinicalApplied and environmental microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Piperacillin-tazobactam resistance inAntimicrobial agents and chemotherapy · 2026
    Article
  14. Article
  15. Genomic analysis ofbioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Molecular evaluation of colistin resistance inIranian journal of microbiology · 2026
    Article
  18. Article
  19. Article
  20. Epidemiological Insights into Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article

681 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laure DiancourtUnité Biodiversité des Bactéries Pathogènes Emergentes (U389 INSERM), Institut Pasteur, 25-28 rue du Dr Roux, 75724 Paris, Cedex 15, France.
Virginie Passet
Jan Verhoef
Patrick A D Grimont
Sylvain Brisse

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multilocus sequence typing (MLST) scheme was developed for Klebsiella pneumoniae. Sequences of seven housekeeping genes were obtained for 67 K. pneumoniae strains, including 19 ceftazidime- and ciprofloxacin-resistant isolates. Forty distinct allelic profiles were identified. MLST data were validated against ribotyping and showed high (96%) discriminatory power. The MLST approach provides unambiguous data useful for the epidemiology of K. pneumoniae isolates.

Indexed as

Bacterial Typing TechniquesBase SequenceCross InfectionDrug Resistance, BacterialHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsMolecular Sequence DataRibotypingSequence Analysis, DNA

Identifiers

PMID16081970
PMCPMC1233940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.